RMTIROCKWELL MEDICAL, INC.vs its industry peers
A metric-by-metric comparison of ROCKWELL MEDICAL, INC. against Pharmaceutical Preparations — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| RMTIThis | $32M#9 | 263.5x#4 | 0.9x#5 | 0.5x#2 | -31.8%#5 | -1007.1%#16 | -6.8%#1 | -15.1%#2 | -14.0%#2 | 4#2 | -40.8%#8 | — |
| CRVO | $38M#4 | 0.0x#1 | 1.6x#8 | 9.4x#7 | -58.9%#7 | -65.6%#11 | -706.2%#6 | -117.5%#9 | -5165.9%#6 | — | -69.2%#14 | — |
| KPTI | $40M#1 | — | — | 0.3x#1 | 0.6%#2 | -156.5%#13 | -62.1%#2 | — | — | — | -69.2%#15 | — |
| ATNM | $38M#3 | 3.4x#3 | 1.2x#7 | 419.2x#9 | — | 11.4%#4 | -40274.4%#9 | -111.8%#7 | — | — | -25.9%#3 | — |
| LITS | $38M#2 | — | 0.7x#3 | — | -100.0%#9 | -189.7%#14 | — | -28.1%#3 | — | — | -59.2%#10 | — |
| CELU | $37M#5 | — | — | 1.4x#4 | -51.0%#6 | -58.4%#9 | -230.9%#4 | — | -398.1%#5 | — | -40.5%#7 | — |
| CNTX | $35M#6 | — | 0.9x#6 | — | — | -35.2%#8 | — | -94.6%#5 | — | — | -61.3%#11 | — |
| FLNA | $35M#7 | — | 0.5x#1 | 0.8x#3 | 277.6%#1 | -273.7%#15 | -232.0%#5 | -133.5%#11 | — | — | -68.7%#13 | — |
| BRNS | $31M#11 | — | 0.5x#2 | — | -100.0%#9 | -8.8%#5 | — | -116.4%#8 | — | — | -37.0%#4 | — |
| KYNB | $31M#13 | 0.2x#2 | — | 4.8x#5 | -78.3%#8 | 485.6%#1 | -712.7%#7 | — | — | — | -37.9%#5 | — |
| RNAZ | $31M#14 | — | — | — | — | -106.9%#12 | — | — | — | — | -83.9%#16 | — |
| ABVC | $31M#10 | — | 3.0x#9 | 105.4x#8 | 0.0%#3 | -61.3%#10 | -2416.0%#8 | -76.9%#4 | -68.5%#3 | — | -57.1%#9 | — |
| CPHI | $31M#12 | — | 0.9x#4 | 7.5x#6 | -8.5%#4 | 32.7%#3 | -78.2%#3 | -8.8%#1 | -7.7%#1 | 5#1 | -63.5%#12 | — |
| MIRA | $33M#8 | — | 4.0x#11 | — | — | -33.0%#7 | — | -127.9%#10 | — | — | -39.1%#6 | — |
| NNVC | $31M#15 | — | 3.4x#10 | — | — | -14.1%#6 | — | -103.4%#6 | -89.9%#4 | — | 0.0%#1 | — |
| HEPA | $29M#16 | — | 22.4x#12 | — | — | 37.3%#2 | — | -647.5%#12 | — | — | -17.6%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Table built 2026-09-18.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice